Company snapshot
Market Cap
$142B
Large-cap2016 — today
10-Year Price
+198%
2016 — today
52-Week Range
$161.91$242.05
Current $200.53· 48%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where DHR stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| VRTXVertex Pharmaceuticals Incorporated | 30.0 | — |
| BMYBristol-Myers Squibb Company | 14.0 | 3.9% |
| ISRGIntuitive Surgical, Inc. | 41.0 | — |
| PFEPfizer Inc. | 36.5 | 6.2% |
| CVSCVS Health Corporation | 25.2 | 2.8% |
| MDTMedtronic plc | 22.6 | 3.1% |
| GILDGilead Sciences, Inc. | -54.2 | 2.2% |
| ABTAbbott Laboratories | 33.2 | 2.4% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
35.6
Above average
Pricier than usual over the last 10 years
Sector median 24.5above sector
P/B ratio
2.7
Below average
Below the 10-year average
Sector median 2.5in line with sector
EV / EBITDA
22.9
Above average
Pricier than usual over the last 10 years
Sector median 15.2above sector
Dividend Yield
0.7%
Historically high
Historically high relative to the last 10 years
Sector median 1.9%below sector
FCF Yield
3.9%
Around average
Around the 10-year average
Sector median -10.0%above sector